Shimmick Corporation Announces Third Quarter 2025 Results

Shimmick Corporation Announces Third Quarter 2025 Results GlobeNewswire November 13, 2025 IRVINE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, electrical and other critical infrastructure construction services, today announced financial results for the third quarter ended October 3, 2025. Third Quarter 2025 and Recent Highlights […]

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

(NASDAQ:ICU), Business highlights include: Three new top-rated children's hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI) Commercial use of QUELIMMUNE therapy demonstrates positive survival results as reported from the QUELIMMUNE SAVE Surveillance Registry New clinical sites added to expand adult NEUTRALIZE-AKI pivotal trial enrollment Strengthened the balance sheet, raising $12.4 million to

Hudson Technologies Appoints Kenneth Gaglione as Chairman of the Board, President and Chief Executive Officer

Hudson Technologies Appoints Kenneth Gaglione as Chairman of the Board, President and Chief Executive Officer GlobeNewswire November 13, 2025 WOODCLIFF LAKE, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) — Hudson Technologies, Inc. (NASDAQ: HDSN) (the “Company”) today announced that its Board of Directors has appointed Kenneth Gaglione as Chairman of the Board, President and Chief Executive

Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results

(NASDAQ:VXRT),(OTC US:VXRT),(Other OTC:VXRT), Entered into an exclusive license agreement with Dynavax for the Company's COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties Completed enrollment of approximately 5,400 participants in COVID-19 Phase 2b trial with topline data expected in late 2026; Topline data from 400-person sentinel cohort anticipated

RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update GlobeNewswire November 13, 2025 September 30, 2025 Cash and Cash Equivalents at $10 million Revenue Expected to Grow in 2026 and Continue to Offset Cash Burn Management to Host Conference Call Today at 4:30 p.m. ET MOUNTAIN VIEW,

Xos Extends Profitability Streak with Strong Q3 2025 Performance and Positive Operating Cash Flow

Xos Extends Profitability Streak with Strong Q3 2025 Performance and Positive Operating Cash Flow GlobeNewswire November 13, 2025 Delivered 130 units and generated $16.5 million in revenue Achieved 15.3% Gross Margin and a second consecutive quarter of positive free cash flow Continued cost discipline with 24% year-over-year reduction in third quarter operating expenses LOS ANGELES,

Expion360 Reports Third Quarter 2025 Financial and Operational Results

(NASDAQ:XPON), Q3 2025 Sales Growth of 72% to $2.4 Million Driven by Continued Demand for Battery Products, Accessories and Technologies New CEO to Drive Next Phase of Growth and Expansion REDMOND, Ore., Nov. 13, 2025 (GLOBE NEWSWIRE) — Expion360 Inc. (Nasdaq: XPON) (“Expion360” or the “Company”), an industry leader in lithium-ion battery power storage, today

Jefferson Capital Reports Third Quarter 2025 Results

Jefferson Capital Reports Third Quarter 2025 Results GlobeNewswire November 13, 2025 Collections Grow 63% to $236.8 Million and Deployments Grow 22% to $151.0 MillionPre-tax Income up 16% to $45.5 Million with Net Income of $38.4 Million and EPS of $0.59Adjusted Pre-tax Income up 30% to $54.8 Million with Adjusted Net Income of $47.7 Million and

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025

(NASDAQ:ICCC), PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended September 30,

Intchains Group Limited Reports Third Quarter and Nine Months 2025 Financial Results

(NASDAQ:ICG), Launches New High-Performing XTM Mining Products to Support Revenue Growth in Q4 2025 Initiates ETH Staking with FalconX with Initial 1,000 ETH in Place Acquisition of Proof-of-Stake Platform to Advance Cryptocurrency Staking Business SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) — Intchains Group Limited (Nasdaq: ICG) (“we,” or the “Company”), a company engaged in the

Scroll to Top